Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02ZIQ
|
|||
| Former ID |
DNC010130
|
|||
| Drug Name |
1-(3-chlorophenyl)-2-(piperidin-1-yl)propan-1-one
|
|||
| Synonyms |
2-Piperidino-3'-chloropropiophenone
Click to Show/Hide
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H18ClNO
|
|||
| Canonical SMILES |
CC(C(=O)C1=CC(=CC=C1)Cl)N2CCCCC2
|
|||
| InChI |
1S/C14H18ClNO/c1-11(16-8-3-2-4-9-16)14(17)12-6-5-7-13(15)10-12/h5-7,10-11H,2-4,8-9H2,1H3
|
|||
| InChIKey |
LOWDJVQAZMFOLZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. J Med Chem. 2010 Mar 11;53(5):2204-14. | |||
| REF 2 | Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. J Med Chem. 2009 Nov 12;52(21):6768-81. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.